Author

S. Maddocks

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:virus· 3 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:statistical model· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:phylogenetics / evolution· 1 Research Focus:transcription & RNA processing· 1

Frequent Co-Authors

J. Kok· 4 shared K. Basile· 4 shared V. Sintchenko· 4 shared A. Arnott· 3 shared C. Lam· 3 shared D. E. Dwyer· 3 shared R. J. Rockett· 3 shared D. Ko· 2 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

J. Kok

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Genomic evolution of SARS-CoV-2 variants of concern under in vitro neutralising selection pressure following two doses of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine

K. Basile, J. E. Agius, W. Fong, K. McPhie, M. Fennel, D. Ko, L. Hueston, C. Lam, A. Arnott, S. C.-A. Chen, S. Maddocks, M. V. N. O Sullivan, D. Dwyer, V. Sintchenko, J. Kok, , CIDMLS COVID-19 Study Group

This study assesses the neutralizing antibody titres against SARS-CoV-2 variants Delta and Beta post-Pfizer-BioNTech vaccination, finding significant reductions compared to wild-type virus.

bioRxiv · Sep 24, 2023 · PreprintMicrobiology

Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting

K. Basile, R. J. Rockett, K. McPhie, M. Fennell, J. Johnson-Mackinnon, J. Agius, W. Fong, H. Rahman, D. Ko, L. Donavan, L. Hueston, C. Lam, A. Arnott, S. Chen, S. Maddocks, , J. Kok

This study shows that Pfizer-BioNTech vaccine boosting increases neutralizing antibodies against Omicron, but they are still lower than against the A.2.2 lineage.

bioRxiv · Dec 12, 2021 · PreprintMicrobiology

REVEALING COVID-19 TRANSMISSION BY SARS-CoV-2 GENOME SEQUENCING AND AGENT BASED MODELLING

R. J. Rockett, A. Arnott, C. Lam, R. Sadsad, V. Timms, K.-A. Gray, J.-S. Eden, S. L. Chang, M. Gall, J. Draper, E. Sim, N. L. Bachmann, I. Carter, K. Basile, R. Byun, , V. Sintchenko

The paper uses SARS-CoV-2 genome sequencing and agent-based modeling to estimate local transmission rates during the early stages of the COVID-19 outbreak in New South Wales.

bioRxiv · Apr 19, 2020 · PreprintMicrobiology

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran

J.-S. Eden, R. Rockett, I. Carter, H. Rahman, J. de Ligt, J. Hadfield, M. Storey, X. Ren, R. Tulloch, K. Basile, J. Wells, R. Byun, N. Gliroy, M. V. O'Sullivan, V. Sintchenko, , J. Kok

The paper identifies a distinct SARS-CoV-2 clade linked to travellers returning from Iran to Australia and New Zealand through whole genome sequencing and phylogenetic analysis.

bioRxiv · Mar 15, 2020Microbiology